HCA Healthcare, Inc. (HCA) 10-Year Financial Performance & Capital Metrics

HCA • • Industrial / General

HealthcareHealthcare FacilitiesHospital & Acute Care FacilitiesGeneral Acute Care Hospitals

AboutHCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.Show more

Revenue $70.6B +8.7%
EBITDA $13.86B +9.1%
Net Income $5.76B +9.9%
EPS (Diluted) 22.00 +16.0%
Gross Margin 14.94% +0.8%
EBITDA Margin 19.63% +0.4%
Operating Margin 14.94% +0.8%
Net Margin 8.16% +1.1%
ROE 713.31% -32.8%
ROIC 18.43% +3.6%
Debt/Equity 81.51 +106.4%
Interest Coverage 5.12 +3.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Excellent 3Y average ROE of 857.5%
✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Share count reduced 5.3% through buybacks
✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

✗High debt to equity ratio of 81.5x
✗Expensive at 228.2x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y6.7%

5Y6.58%

3Y6.32%

TTM6.82%

Profit (Net Income) CAGR

10Y11.88%

5Y10.45%

3Y-6.1%

TTM7.52%

EPS CAGR

10Y18.12%

5Y16.92%

3Y1.31%

TTM16.06%

ROCE

10Y Avg21.9%

5Y Avg22.26%

3Y Avg22.67%

Latest24%

Peer Comparison

General Acute Care Hospitals

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
HCAHCA Healthcare, Inc.	110.4B	483.80	21.99	8.67%	8.57%	7.13%	5.11%	81.51
UHSUniversal Health Services, Inc.	11.28B	204.19	12.14	10.82%	8.09%	18.85%	9.96%	0.73
THCTenet Healthcare Corporation	17.69B	201.32	6.16	0.57%	6.49%	15.56%	6.31%	1.68
ARDTArdent Health Partners, LLC	1.27B	8.90	5.63	10.29%	3.24%	12.57%	10.01%	1.50
AUNAAuna S.A.	138.14M	4.59	2.82	14.47%	4.33%	10.05%	100%	2.32
CYHCommunity Health Systems, Inc.	462.66M	3.34	-0.86	1.15%	2.6%		25.94%

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	39.68B	41.49B	43.61B	46.68B	51.34B	51.53B	58.75B	60.23B	64.97B	70.6B
Revenue Growth %	0.07%	0.05%	0.05%	0.07%	0.1%	0%	0.14%	0.03%	0.08%	0.09%
Cost of Goods Sold+	33.42B	34.87B	37.09B	39.64B	43.62B	44.27B	49.07B	51.18B	55.34B	60.06B
COGS % of Revenue	0.84%	0.84%	0.85%	0.85%	0.85%	0.86%	0.84%	0.85%	0.85%	0.85%
Gross Profit+	6.26B	6.62B	6.52B	7.04B	7.71B	7.26B	9.68B	9.05B	9.63B	10.55B
Gross Margin %	0.16%	0.16%	0.15%	0.15%	0.15%	0.14%	0.16%	0.15%	0.15%	0.15%
Gross Profit Growth %	0.07%	0.06%	-0.01%	0.08%	0.1%	-0.06%	0.33%	-0.06%	0.06%	0.1%
Operating Expenses+	344M	430M	466M	447M	497M	0	0	0	0	0
OpEx % of Revenue	0.01%	0.01%	0.01%	0.01%	0.01%	-	-	-	-	-
Selling, General & Admin	0	0	0	0	0	0	0	0	0	31.17B
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	0.44%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	344M	430M	466M	447M	497M	0	0	0	0	-31.17B
Operating Income+	5.92B	6.19B	6.06B	6.59B	7.22B	7.26B	9.68B	9.05B	9.63B	10.55B
Operating Margin %	0.15%	0.15%	0.14%	0.14%	0.14%	0.14%	0.16%	0.15%	0.15%	0.15%
Operating Income Growth %	0.09%	0.05%	-0.02%	0.09%	0.09%	0.01%	0.33%	-0.06%	0.06%	0.1%
EBITDA+	7.82B	8.15B	8.19B	8.87B	9.81B	9.98B	12.53B	12.02B	12.7B	13.86B
EBITDA Margin %	0.2%	0.2%	0.19%	0.19%	0.19%	0.19%	0.21%	0.2%	0.2%	0.2%
EBITDA Growth %	0.08%	0.04%	0%	0.08%	0.11%	0.02%	0.26%	-0.04%	0.06%	0.09%
D&A (Non-Cash Add-back)	1.9B	1.97B	2.13B	2.28B	2.6B	2.72B	2.85B	2.97B	3.08B	3.31B
EBIT	5.5B	6.41B	6.05B	7.1B	7.08B	6.99B	11.36B	10.32B	9.64B	10.58B
Net Interest Income+	-1.54B	-1.6B	-1.67B	-1.76B	-1.84B	-1.56B	-1.53B	-1.74B	-1.94B	-2.06B
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	1.54B	1.6B	1.67B	1.76B	1.84B	1.56B	1.53B	1.74B	1.94B	2.06B
Other Income/Expense	-1.96B	-1.38B	-1.68B	-1.26B	-1.97B	-1.83B	155M	-473M	-1.92B	-2.02B
Pretax Income+	3.96B	4.81B	4.38B	5.33B	5.24B	5.43B	9.83B	8.58B	7.71B	8.52B
Pretax Margin %	0.1%	0.12%	0.1%	0.11%	0.1%	0.11%	0.17%	0.14%	0.12%	0.12%
Income Tax+	1.26B	1.38B	1.64B	946M	1.1B	1.04B	2.11B	1.75B	1.61B	1.87B
Effective Tax Rate %	0.54%	0.6%	0.51%	0.71%	0.67%	0.69%	0.71%	0.66%	0.68%	0.68%
Net Income+	2.13B	2.89B	2.22B	3.79B	3.5B	3.75B	6.96B	5.64B	5.24B	5.76B
Net Margin %	0.05%	0.07%	0.05%	0.08%	0.07%	0.07%	0.12%	0.09%	0.08%	0.08%
Net Income Growth %	0.14%	0.36%	-0.23%	0.71%	-0.07%	0.07%	0.85%	-0.19%	-0.07%	0.1%
Net Income (Continuing)	2.7B	3.43B	2.74B	4.39B	4.14B	4.39B	7.72B	6.83B	6.09B	6.66B
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	1.55B	1.67B	1.81B	2.03B	2.24B	2.32B	2.42B	2.69B	2.83B	3.05B
EPS (Diluted)+	4.99	7.30	5.95	10.66	10.07	10.93	21.16	19.15	18.96	22.00
EPS Growth %	0.2%	0.46%	-0.18%	0.79%	-0.06%	0.09%	0.94%	-0.09%	-0.01%	0.16%
EPS (Basic)	5.34	7.80	6.33	11.04	10.27	11.10	21.51	19.44	19.24	22.27
Diluted Shares Outstanding	426.72M	395.85M	372.22M	355.3M	348.23M	343.61M	328.75M	294.67M	276.41M	261.81M
Basic Shares Outstanding	398.74M	370.54M	350.09M	342.9M	341.21M	338.27M	323.31M	290.35M	272.4M	258.6M
Dividend Payout Ratio	-	-	-	0.13%	0.16%	0.04%	0.09%	0.12%	0.13%	0.12%

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	9.23B	9.09B	9.98B	10.21B	11.2B	12.33B	13.54B	13.64B	14.93B	16.41B
Cash & Short-Term Investments	741M	646M	732M	502M	621M	1.79B	1.45B	908M	935M	2.02B
Cash Only	741M	646M	732M	502M	621M	1.79B	1.45B	908M	935M	1.93B
Short-Term Investments	0	0	0	0	0	0	0	0	0	88M
Accounts Receivable	5.89B	5.83B	6.5B	6.79B	7.38B	7.05B	8.1B	8.89B	9.96B	10.75B
Days Sales Outstanding	54.17	51.25	54.41	53.09	52.47	49.94	50.29	53.88	55.95	55.58
Inventory	1.44B	1.5B	1.57B	1.73B	1.85B	2.02B	1.99B	2.07B	2.02B	1.74B
Days Inventory Outstanding	15.72	15.73	15.48	15.95	15.47	16.7	14.77	14.75	13.33	10.56
Other Current Assets	1.16B	1.11B	1.17B	1.19B	1.35B	1.46B	2.01B	1.78B	2.01B	1.9B
Total Non-Current Assets+	23.51B	24.67B	26.62B	28.99B	33.86B	35.16B	37.2B	38.8B	41.28B	43.1B
Property, Plant & Equipment	15.01B	16.35B	17.89B	19.76B	24.55B	25.22B	26.18B	27.64B	29.92B	31.55B
Fixed Asset Turnover	2.64x	2.54x	2.44x	2.36x	2.09x	2.04x	2.24x	2.18x	2.17x	2.24x
Goodwill	6.34B	6.33B	7.04B	7.61B	7.94B	8.21B	9.14B	9.29B	9.61B	9.77B
Intangible Assets	393M	374M	359M	342M	330M	369M	403M	359M	339M	323M
Long-Term Investments	610M	542M	617M	594M	564M	810M	886M	1.2B	1.23B	1.23B
Other Non-Current Assets	1.16B	1.07B	710M	690M	480M	546M	598M	298M	184M	230M
Total Assets+	32.74B	33.76B	36.59B	39.21B	45.06B	47.49B	50.74B	52.44B	56.21B	59.51B
Asset Turnover	1.21x	1.23x	1.19x	1.19x	1.14x	1.09x	1.16x	1.15x	1.16x	1.19x
Asset Growth %	0.05%	0.03%	0.08%	0.07%	0.15%	0.05%	0.07%	0.03%	0.07%	0.06%
Total Current Liabilities+	5.52B	5.83B	6.16B	7.57B	7.76B	8.7B	9.58B	9.9B	12.65B	15.18B
Accounts Payable	2.17B	2.32B	2.61B	2.58B	2.9B	3.54B	4.11B	4.24B	4.23B	4.28B
Days Payables Outstanding	23.7	24.26	25.64	23.73	24.31	29.14	30.58	30.23	27.92	25.99
Short-Term Debt	233M	216M	200M	788M	145M	209M	237M	370M	2.42B	4.7B
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	0	0	67M	459M	528M	547M	549M	794M	867M	910M
Current Ratio	1.67x	1.56x	1.62x	1.35x	1.44x	1.42x	1.41x	1.38x	1.18x	1.08x
Quick Ratio	1.41x	1.30x	1.36x	1.12x	1.20x	1.18x	1.21x	1.17x	1.02x	0.97x
Cash Conversion Cycle	46.19	42.72	44.24	45.31	43.64	37.49	34.49	38.39	41.36	40.15
Total Non-Current Liabilities+	33.27B	33.56B	35.43B	34.56B	37.87B	35.89B	39.67B	42.61B	42.5B	43.78B
Long-Term Debt	30.25B	31.16B	32.86B	32.03B	33.58B	30.8B	33.77B	37.13B	37.17B	38.33B
Capital Lease Obligations	0	0	0	0	1.5B	1.67B	2.33B	2.33B	1.9B	1.86B
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	3.02B	2.4B	2.57B	2.52B	2.79B	3.43B	3.57B	3.14B	3.42B	3.58B
Total Liabilities	38.79B	39.39B	41.59B	42.13B	45.62B	44.6B	49.25B	52.51B	55.15B	58.96B
Total Debt+	30.49B	31.38B	33.06B	32.82B	35.57B	33.06B	36.73B	40.2B	41.86B	45.24B
Net Debt	29.75B	30.73B	32.33B	32.32B	34.95B	31.26B	35.27B	39.29B	40.92B	43.3B
Debt / Equity	-	-	-	-	-	11.43x	24.66x	-	39.49x	81.51x
Debt / EBITDA	3.90x	3.85x	4.04x	3.70x	3.62x	3.31x	2.93x	3.34x	3.29x	3.26x
Net Debt / EBITDA	3.80x	3.77x	3.95x	3.64x	3.56x	3.13x	2.82x	3.27x	3.22x	3.12x
Interest Coverage	3.84x	3.87x	3.63x	3.74x	3.92x	4.66x	6.33x	5.21x	4.97x	5.12x
Total Equity+	-6.05B	-5.63B	-5B	-2.92B	-565M	2.89B	1.49B	-73M	1.06B	555M
Equity Growth %	0.07%	0.07%	0.11%	0.42%	0.81%	6.12%	-0.49%	-1.05%	15.52%	-0.48%
Book Value per Share	-14.17	-14.23	-13.42	-8.21	-1.62	8.42	4.53	-0.25	3.83	2.12
Total Shareholders' Equity	-7.6B	-7.3B	-6.81B	-4.95B	-2.81B	572M	-933M	-2.77B	-1.77B	-2.5B
Common Stock	4M	4M	4M	3M	3M	3M	3M	3M	3M	3M
Retained Earnings	-7.34B	-6.97B	-6.53B	-4.57B	-2.35B	777M	-532M	-2.28B	-1.35B	-2.12B
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-265M	-338M	-278M	-381M	-460M	-502M	-404M	-490M	-425M	-387M
Minority Interest	1.55B	1.67B	1.81B	2.03B	2.24B	2.32B	2.42B	2.69B	2.83B	3.05B

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	4.73B	5.65B	5.43B	6.76B	7.6B	9.23B	8.96B	8.52B	9.43B	10.51B
Operating CF Margin %	0.12%	0.14%	0.12%	0.14%	0.15%	0.18%	0.15%	0.14%	0.15%	0.15%
Operating CF Growth %	0.06%	0.19%	-0.04%	0.25%	0.12%	0.21%	-0.03%	-0.05%	0.11%	0.11%
Net Income	2.7B	3.43B	2.74B	4.39B	4.14B	4.39B	7.72B	6.83B	5.24B	6.66B
Depreciation & Amortization	1.9B	1.97B	2.13B	2.28B	2.6B	2.72B	2.85B	2.97B	3.08B	3.31B
Stock-Based Compensation	239M	251M	270M	268M	347M	362M	440M	341M	262M	360M
Deferred Taxes	-160M	123M	433M	74M	250M	41M	-70M	571M	229M	22M
Other Non-Cash Items	378M	-161M	145M	-281M	352M	443M	-1.48B	-1.04B	1.08B	269M
Working Capital Changes	-323M	42M	-296M	33M	-88M	1.28B	-503M	-1.15B	-457M	-106M
Change in Receivables	-4.11B	-3.25B	-4.64B	-423M	-326M	327M	-962M	-797M	0	-799M
Change in Inventory	-314M	-112M	-69M	-242M	-158M	-304M	-540M	-59M	0	334M
Change in Payables	192M	144M	374M	698M	396M	1.25B	999M	-296M	0	359M
Cash from Investing+	-2.58B	-3.24B	-4.28B	-3.9B	-5.72B	-3.39B	-2.64B	-3.39B	-5.32B	-4.93B
Capital Expenditures	-2.38B	-2.76B	-3.02B	-3.57B	-4.16B	-2.83B	-3.58B	-4.39B	-4.74B	-4.88B
CapEx % of Revenue	0.06%	0.07%	0.07%	0.08%	0.08%	0.06%	0.06%	0.07%	0.07%	0.07%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	70M	96M	-52M	60M	59M	-58M	-121M	-7M	-131M	-58M
Cash from Financing+	-1.98B	-2.51B	-1.06B	-3.08B	-1.77B	-4.68B	-6.66B	-5.66B	-4.09B	-4.58B
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	-487M	-550M	-153M	-624M	-653M	-661M	-690M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-357M	-572M	-519M	-714M	-757M	-866M	-1.07B	-1.29B	-917M	-1.05B
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	2.36B	2.89B	2.41B	3.19B	3.44B	6.4B	5.38B	4.13B	4.69B	5.64B
FCF Margin %	0.06%	0.07%	0.06%	0.07%	0.07%	0.12%	0.09%	0.07%	0.07%	0.08%
FCF Growth %	0.04%	0.23%	-0.17%	0.32%	0.08%	0.86%	-0.16%	-0.23%	0.14%	0.2%
FCF per Share	5.53	7.31	6.48	8.97	9.89	18.62	16.37	14.01	16.96	21.54
FCF Conversion (FCF/Net Income)	2.22x	1.96x	2.45x	1.79x	2.17x	2.46x	1.29x	1.51x	1.80x	1.83x
Interest Paid	1.65B	1.67B	1.7B	1.74B	1.91B	1.61B	1.5B	1.66B	1.89B	1.94B
Taxes Paid	1.19B	1.25B	1.21B	872M	849M	1B	2.18B	1.18B	1.39B	1.84B

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-	-	-	322.65%	317.55%	797.03%	1062.21%	713.31%
Return on Invested Capital (ROIC)	19.27%	19.02%	17.33%	17.43%	16.97%	15.89%	20.47%	17.87%	17.78%	18.43%
Gross Margin	15.78%	15.95%	14.96%	15.08%	15.03%	14.09%	16.47%	15.03%	14.82%	14.94%
Net Margin	5.37%	6.97%	5.08%	8.11%	6.83%	7.28%	11.84%	9.37%	8.07%	8.16%
Debt / Equity	-	-	-	-	-	11.43x	24.66x	-	39.49x	81.51x
Interest Coverage	3.84x	3.87x	3.63x	3.74x	3.92x	4.66x	6.33x	5.21x	4.97x	5.12x
FCF Conversion	2.22x	1.96x	2.45x	1.79x	2.17x	2.46x	1.29x	1.51x	1.80x	1.83x
Revenue Growth	7.48%	4.57%	5.12%	7.02%	9.98%	0.38%	14.01%	2.52%	7.86%	8.67%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Managed Care And Other Insurers	21.88B	23.44B	24.81B	24.47B	26.54B	26.54B	30.3B	29.12B	31.82B	34.95B
Managed Care And Other Insurers Growth	-	7.12%	5.85%	-1.39%	8.49%	-0.03%	14.17%	-3.88%	9.27%	9.85%
Managed Medicare	4.13B	4.36B	4.79B	5.5B	6.45B	7B	8.42B	9.2B	10.5B	11.99B
Managed Medicare Growth	-	5.37%	9.94%	14.81%	17.37%	8.45%	20.39%	9.22%	14.07%	14.21%
Medicare	8.65B	8.89B	9.48B	9.83B	10.8B	10.42B	10.45B	10.45B	10.59B	10.78B
Medicare Growth	-	2.78%	6.61%	3.67%	9.84%	-3.50%	0.26%	0.00%	1.32%	1.84%
Medicaid	1.71B	1.6B	1.63B	1.36B	1.57B	1.97B	2.29B	2.64B	3.61B	4.68B
Medicaid Growth	-	-6.33%	2.13%	-16.74%	15.76%	25.00%	16.54%	15.11%	36.80%	29.73%
Managed Medicaid	2.23B	2.48B	2.35B	2.4B	2.45B	2.62B	3.12B	4B	3.88B	3.98B
Managed Medicaid Growth	-	10.92%	-5.21%	2.30%	1.96%	6.98%	19.19%	27.98%	-2.98%	2.60%
International	1.29B	1.2B	1.1B	1.16B	1.16B	1.12B	1.34B	1.32B	1.51B	1.68B
International Growth	-	-7.72%	-8.20%	5.38%	0.52%	-3.61%	19.29%	-1.42%	14.58%	11.46%

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
American Group	18.87B	19.65B	20.91B	21.96B	23.17B	23.59B	26.15B	26.86B	22.32B	24.6B
American Group Growth	-	4.11%	6.43%	5.01%	5.53%	1.81%	10.85%	2.73%	-16.93%	10.23%
Atlantic Group	-	-	-	-	-	-	-	-	21.17B	23.17B
Atlantic Group Growth	-	-	-	-	-	-	-	-	-	9.47%
National Group	18.76B	19.84B	20.77B	22.58B	25.91B	25.69B	29.83B	30.35B	18.11B	19.61B
National Group Growth	-	5.81%	4.67%	8.71%	14.76%	-0.85%	16.08%	1.76%	-40.35%	8.33%
Corporate and Other	2.05B	2B	1.93B	2.14B	2.25B	2.25B	2.77B	3.02B	3.38B	-
Corporate and Other Growth	-	-2.59%	-3.36%	10.73%	5.29%	-0.18%	23.51%	8.80%	11.93%	-

Frequently Asked Questions

Valuation & Price

HCA Healthcare, Inc. (HCA) has a price-to-earnings (P/E) ratio of 22.0x. This is roughly in line with market averages.

Growth & Financials

HCA Healthcare, Inc. (HCA) reported $74.37B in revenue for fiscal year 2024. This represents a 129% increase from $32.51B in 2011.

HCA Healthcare, Inc. (HCA) grew revenue by 8.7% over the past year. This is steady growth.

Yes, HCA Healthcare, Inc. (HCA) is profitable, generating $6.38B in net income for fiscal year 2024 (8.2% net margin).

Dividend & Returns

Yes, HCA Healthcare, Inc. (HCA) pays a dividend with a yield of 0.54%. This makes it attractive for income-focused investors.

HCA Healthcare, Inc. (HCA) has a return on equity (ROE) of 713.3%. This is excellent, indicating efficient use of shareholder capital.

HCA Healthcare, Inc. (HCA) generated $8.10B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...